Brief: Microba Life Sciences Posts H1 Revenue Result Of A$3.27M
28/02/2024 01:32
Feb 28 (Reuters) - Microba Life Sciences Ltd MAP.AX :
* H1 REVENUE RESULT OF A$3.27M, UP 52% YOY
* LOSS FOR HALF-YEAR ATTRIBUTABLE A$11.5 MILLION
Source text for Eikon: ID:nASX4qvbT
Further company coverage: MAP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microba Life Sciences
See all newsBrief: Genetic Signatures Says Microba Shareholders To Hold 60% Of GSS On Merger
Brief: Microba Life Sciences Announces Placement Via Two Tranches
Brief: Microba Life Sciences Appoints Geoffrey Cockerill As Interim CEO
Australia's Genetic Signatures climbs on potential merger with Microba
Brief: Microba Life Sciences Says Microba Signs Multi-Year Synlab Agreement